HANGZHOU, China and SHAOXING, China, Aug. 30, 2018 /PRNewswire/ -- Ascletis Pharma Inc.(1672.HK) announced today that Mr. Joshua Zhongbao Ling joined Ascletis as Vice President of Finance. Mr. Ling will be responsible for the corporate finance management.
"We are excited to have Joshua on board," said Jinzi J. Wu, PhD., Founder,
"It is a great honor to join Ascletis, a dynamic biopharmaceutical pioneer. I am holding full confidence about the future development of Ascletis. I look forward to working with my fellow colleagues to contribute our mission to become a world-class biotechnology company addressing unmet medical needs." Mr. Ling commented.
Mr. Ling has over 22 years of experience in auditing, corporate finance etc. working with numerous private and public companies globally. Prior to joining Ascletis, he was Group Senior Finance Director at Golden Concord Holdings Limited, parent company of GCL-poly Energy Holdings Limited (3800.hk) and GCL New Energy Holdings Limited (0451.hk), and Asia Pacific Financial Controller at Chamberlain Group Inc. after working at Grant Thornton as an auditor. He had good international exposure and strong impact and influence to people as a powerful communicator. He got a bachelor's degree in Audit from Capital University of Economics & Trade and received an FMBA degree from Chinese University of Hong Kong. He is a fellow member of the Chartered Global Management Accountant, fellow member of Institute of Public Accountants, Australia and fellow member of UK financial Accountant.
View original content:http://www.prnewswire.com/news-releases/ascletis-appoints-mr-joshua-zhongbao-ling-as-vp-finance-300704717.html
SOURCE Ascletis Pharma Inc.
Subscribe to our Free Newsletters!
Self-medication is treating self with non-prescription or over the counter medications, for ...
Art of gardening can improve socializing and cognitive skills in children and elderly. As a therapy ...
Prunes are dried plums that are packed with nutrients like vitamins and minerals that are essential ...View All